(Q43283807)

English

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

scientific article published on 27 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

0 references

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

chronic obstructive pulmonary disease

0 references

Theodore C. Lystig

4

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

author name string

Marc Decramer

1

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Bartolome Celli

2

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Steven Kesten

3

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Sunil Mehra

5

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Donald P Tashkin

6

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

UPLIFT investigators

7

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

language of work or name

0 references

publication date

27 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

374

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

9696

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

1171-1178

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchodilator efficacy of tiotropium in patients with mild to moderate COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Airway obstruction is common but unsuspected in patients admitted to a general medicine service.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Underdiagnosis and undertreatment of COPD in primary care settings.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Office spirometry significantly improves early detection of COPD in general practice: the DIDASCO Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961298-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)61298-8

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43283807&oldid=2148450334"